Home » Novel Heart Disease Diagnostic Would Measure Risk by Testing the Gut
Novel Heart Disease Diagnostic Would Measure Risk by Testing the Gut
April 20, 2012
The saying that the way to a man’s heart is through the stomach might be true in more ways than one. Diagnostics company LipoScience is developing a new cardiovascular disease test that would use gut flora as a biomarker for cardiovascular risks.
MedCity News
MedCity News
Upcoming Events
-
21Oct